title: Proprotein-processing endoprotease furin controls growth of pancreatic beta-cells.
abstract: We have previously reported that in the well-differentiated beta-cell line MIN6 cells, the beta-cell-specific differentiated characteristics, such as insulin content, expression of prohormone convertases PC2 and PC3, and glucose-regulated insulin secretion, diminished when the proprotein-processing endoprotease furin was highly expressed. Since furin converts many growth-related protein precursors to their bioactive forms, we compared the four pancreatic islet cell lines RINm5F, betaTC3, betaHC9, and MIN6 with respect to cell growth rate, furin expression, endoprotease activity, and insulin content. RINm5F cells exhibited the strongest furin expression, higher furin-type endoprotease activity, and the fastest cell growth, but had the least insulin content. In contrast, MIN6 cells exhibited only a weak furin expression, little furin-type endoprotease activity, and the slowest cell growth, but had the highest insulin content. To test whether furin-expressing cells secrete growth-promoting factors cleaved by furin, we prepared conditioned media from RINm5F and furin cDNA-introduced MIN6 (MIN6-F) cells. The conditioned media from RINm5F and MIN6-F induced increased DNA synthesis and promoted the growth of normal MIN6 cells, compared with the medium from the empty vector-introduced MIN6-0 cells. We then examined the effect of the protease inhibitors alpha1-antitrypsin and its variants by infecting their vaccinia recombinants to the four cell lines. All conditioned media from each cell line expressing the furin-specific alpha1-antitrypsin variant exhibited the least DNA synthetic capacity on normal MIN6 cells. Furthermore, all three sublines of MIN6-F grew faster than MIN6-0 and MIN6. Thus, we suggest that the islet cells with higher furin expression may induce increased production of growth factors, which result in an increase in cell growth, through an autocrine/paracrine mechanism.
authors.affiliation: Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kayo
authors.forename: Y
authors.initials: Y
authors.lastname: Sawada
authors.forename: M
authors.initials: M
authors.lastname: Suda
authors.forename: Y
authors.initials: Y
authors.lastname: Konda
authors.forename: T
authors.initials: T
authors.lastname: Izumi
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Shibata
authors.forename: T
authors.initials: T
authors.lastname: Takeuchi
mesh_terms: D000818:Animals; D002452:Cell Count / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D017077:Culture Media, Conditioned / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000201:enzymology / Q000648:ultrastructure; D004247:DNA / Q000096:biosynthesis; D045683:Furin; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D007106:Immune Sera / Q000276:immunology; D007150:Immunohistochemistry; D007328:Insulin / Q000032:analysis / Q000276:immunology; D007515:Islets of Langerhans / Q000166:cytology* / Q000201:enzymology* / Q000648:ultrastructure; D009842:Oligopeptides / Q000378:metabolism; D011863:Radioimmunoassay; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013381:Subtilisins / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000494:pharmacology*
chemical_list: D017077:Culture Media, Conditioned; D007106:Immune Sera; D007328:Insulin; D009842:Oligopeptides; D015842:Serine Proteinase Inhibitors; D000515:alpha 1-Antitrypsin; D004247:DNA; D013381:Subtilisins; D045683:Furin